Correlation Between Protagenic Therapeutics and Anebulo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Protagenic Therapeutics and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protagenic Therapeutics and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protagenic Therapeutics and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Protagenic Therapeutics and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protagenic Therapeutics with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protagenic Therapeutics and Anebulo Pharmaceuticals.
Diversification Opportunities for Protagenic Therapeutics and Anebulo Pharmaceuticals
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Protagenic and Anebulo is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Protagenic Therapeutics and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Protagenic Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protagenic Therapeutics are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Protagenic Therapeutics i.e., Protagenic Therapeutics and Anebulo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Protagenic Therapeutics and Anebulo Pharmaceuticals
Given the investment horizon of 90 days Protagenic Therapeutics is expected to generate 1.6 times more return on investment than Anebulo Pharmaceuticals. However, Protagenic Therapeutics is 1.6 times more volatile than Anebulo Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Anebulo Pharmaceuticals is currently generating about -0.17 per unit of risk. If you would invest 64.00 in Protagenic Therapeutics on August 25, 2024 and sell it today you would earn a total of 1.00 from holding Protagenic Therapeutics or generate 1.56% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Protagenic Therapeutics vs. Anebulo Pharmaceuticals
Performance |
| Timeline |
| Protagenic Therapeutics |
| Anebulo Pharmaceuticals |
Protagenic Therapeutics and Anebulo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Protagenic Therapeutics and Anebulo Pharmaceuticals
The main advantage of trading using opposite Protagenic Therapeutics and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protagenic Therapeutics position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.| Protagenic Therapeutics vs. Sino Biopharmaceutical Ltd | Protagenic Therapeutics vs. Eledon Pharmaceuticals | Protagenic Therapeutics vs. Rezolute | Protagenic Therapeutics vs. XOMA Corporation |
| Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |